Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey J Langer

Showing results (91-100 of 225) with videos related to

Pageof 23
Sort By:
JAMA Oncology|June 4, 2023
Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung CancerLova Sun, Benjamin Bleiberg, Wei-Ting Hwang, et al.
American Journal of Clinical Oncology|April 1, 2008
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumorsSteven J Cohen, Paul F Engstrom, Nancy L Lewis, et al.
Clinical Lung Cancer|January 24, 2012
Pemetrexed therapy in elderly patients with good performance status: analysis of two phase III trials of patients with nonsquamous non-small-cell lung cancerCesare Gridelli, Thomas Brodowicz, Corey J Langer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesotheliomaPasi A Jänne, George R Simon, Corey J Langer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Surgical patterns of care in operable lung carcinoma treated with radiationJoe Y Chang, Jennifer Moughan, David W Johnstone, et al.
Head & Neck|February 4, 2009
National Cancer Database report on cancer of the head and neck: 10-year updateJay S Cooper, Kim Porter, Katherine Mallin, et al.
American Journal of Clinical Oncology|January 29, 2015
Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak TrialsCorey J Langer, Mark A Socinski, Jyoti D Patel, et al.
Journal of Radiation Oncology|December 19, 2018
An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential ChemoradiotherapyAndre Konski, Mytheryi Bhargavan, Jean Owen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced non-small cell lung carcinomaCorey J Langer, Robert Somer, Samuel Litwin, et al.
Journal for Immunotherapy of Cancer|October 8, 2020
Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanomaJeffrey C Thompson, Christiana Davis, Charuhas Deshpande, et al.
Pageof 23

Showing results (91-100 of 225) with videos related to

Sort By:
Pageof 23
JAMA Oncology|June 4, 2023
Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung CancerLova Sun, Benjamin Bleiberg, Wei-Ting Hwang, et al.
American Journal of Clinical Oncology|April 1, 2008
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumorsSteven J Cohen, Paul F Engstrom, Nancy L Lewis, et al.
Clinical Lung Cancer|January 24, 2012
Pemetrexed therapy in elderly patients with good performance status: analysis of two phase III trials of patients with nonsquamous non-small-cell lung cancerCesare Gridelli, Thomas Brodowicz, Corey J Langer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesotheliomaPasi A Jänne, George R Simon, Corey J Langer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Surgical patterns of care in operable lung carcinoma treated with radiationJoe Y Chang, Jennifer Moughan, David W Johnstone, et al.
Head & Neck|February 4, 2009
National Cancer Database report on cancer of the head and neck: 10-year updateJay S Cooper, Kim Porter, Katherine Mallin, et al.
American Journal of Clinical Oncology|January 29, 2015
Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak TrialsCorey J Langer, Mark A Socinski, Jyoti D Patel, et al.
Journal of Radiation Oncology|December 19, 2018
An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential ChemoradiotherapyAndre Konski, Mytheryi Bhargavan, Jean Owen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced non-small cell lung carcinomaCorey J Langer, Robert Somer, Samuel Litwin, et al.
Journal for Immunotherapy of Cancer|October 8, 2020
Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanomaJeffrey C Thompson, Christiana Davis, Charuhas Deshpande, et al.
Pageof 23